Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) vs. Ascend Wellness (OTCMKTS:AAWH) Head to Head Contrast

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTFGet Free Report) and Ascend Wellness (OTCMKTS:AAWHGet Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.

Valuation & Earnings

This table compares Recordati Industria Chimica E Farmaceutica and Ascend Wellness”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Recordati Industria Chimica E Farmaceutica $2.96 billion 4.04 $501.92 million $2.80 20.71
Ascend Wellness $500.58 million 0.21 -$118.19 million ($0.57) -0.91

Recordati Industria Chimica E Farmaceutica has higher revenue and earnings than Ascend Wellness. Ascend Wellness is trading at a lower price-to-earnings ratio than Recordati Industria Chimica E Farmaceutica, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

17.3% of Ascend Wellness shares are owned by institutional investors. 21.9% of Ascend Wellness shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Recordati Industria Chimica E Farmaceutica and Ascend Wellness’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Recordati Industria Chimica E Farmaceutica 18.38% 33.73% 12.76%
Ascend Wellness -23.31% -1,099.51% -10.85%

Volatility and Risk

Recordati Industria Chimica E Farmaceutica has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Comparatively, Ascend Wellness has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Recordati Industria Chimica E Farmaceutica and Ascend Wellness, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Recordati Industria Chimica E Farmaceutica 0 1 0 1 3.00
Ascend Wellness 0 1 0 0 2.00

Summary

Recordati Industria Chimica E Farmaceutica beats Ascend Wellness on 10 of the 13 factors compared between the two stocks.

About Recordati Industria Chimica E Farmaceutica

(Get Free Report)

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

About Ascend Wellness

(Get Free Report)

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.

Receive News & Ratings for Recordati Industria Chimica E Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica E Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.